Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viswanath Devanarayan

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
The AAPS Journal|October 7, 2020
Are Lessons Learned in Setting Cut Points for Detection of Anti-Drug Antibodies Also Useful in Serology Assays for Robust Detection of SARS-CoV-2 Reactive Antibodies?Ronald R Bowsher, Viswanath Devanarayan
Journal of Alzheimer'S Disease : JAD|February 1, 2021
Serum Phosphatidylethanolamine and Lysophosphatidylethanolamine Levels Differentiate Alzheimer's Disease from Controls and Predict Progression from Mild Cognitive ImpairmentDaniel A Llano, Viswanath Devanarayan,
Mathematics (Basel, Switzerland)|November 22, 2023
Improving the Robustness of Variable Selection and Predictive Performance of Regularized Generalized Linear Models and Cox Proportional Hazard ModelsFeng Hong, Lu Tian, Viswanath Devanarayan
Journal of Alzheimer'S Disease : JAD|February 19, 2019
Identification of a Simple and Novel Cut-Point Based Cerebrospinal Fluid and MRI Signature for Predicting Alzheimer's Disease Progression that Reinforces the 2018 NIA-AA Research FrameworkPriya Devanarayan, Viswanath Devanarayan, Daniel A Llano, et al.
Neurobiology of Aging|November 11, 2022
CSF peptides from VGF and other markers enhance prediction of MCI to AD progression using the ATN frameworkDaniel A Llano, Priya Devanarayan, Viswanath Devanarayan, et al.
Alzheimer Disease and Associated Disorders|September 18, 2010
Derivation of a new ADAS-cog composite using tree-based multivariate analysis: prediction of conversion from mild cognitive impairment to Alzheimer diseaseDaniel A Llano, Genevieve Laforet, Viswanath Devanarayan, et al.
Alzheimer Disease and Associated Disorders|July 16, 2019
VGF in Cerebrospinal Fluid Combined With Conventional Biomarkers Enhances Prediction of Conversion From MCI to ADDaniel A Llano, Priya Devanarayan, Viswanath Devanarayan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 20, 2018
Intelligent and effective informatic deconvolution of "Big Data" and its future impact on the quantitative nature of neurodegenerative disease therapyStuart Maudsley, Viswanath Devanarayan, Bronwen Martin, et al.
Statistics in Medicine|October 28, 2014
A PRIM approach to predictive-signature development for patient stratificationGong Chen, Hua Zhong, Anton Belousov, et al.
Frontiers in Human Neuroscience|October 11, 2021
Reported Hearing Loss in Alzheimer's Disease Is Associated With Loss of Brainstem and Cerebellar VolumeDaniel A Llano, Susanna S Kwok, Viswanath Devanarayan, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
The AAPS Journal|October 7, 2020
Are Lessons Learned in Setting Cut Points for Detection of Anti-Drug Antibodies Also Useful in Serology Assays for Robust Detection of SARS-CoV-2 Reactive Antibodies?Ronald R Bowsher, Viswanath Devanarayan
Journal of Alzheimer'S Disease : JAD|February 1, 2021
Serum Phosphatidylethanolamine and Lysophosphatidylethanolamine Levels Differentiate Alzheimer's Disease from Controls and Predict Progression from Mild Cognitive ImpairmentDaniel A Llano, Viswanath Devanarayan,
Mathematics (Basel, Switzerland)|November 22, 2023
Improving the Robustness of Variable Selection and Predictive Performance of Regularized Generalized Linear Models and Cox Proportional Hazard ModelsFeng Hong, Lu Tian, Viswanath Devanarayan
Journal of Alzheimer'S Disease : JAD|February 19, 2019
Identification of a Simple and Novel Cut-Point Based Cerebrospinal Fluid and MRI Signature for Predicting Alzheimer's Disease Progression that Reinforces the 2018 NIA-AA Research FrameworkPriya Devanarayan, Viswanath Devanarayan, Daniel A Llano, et al.
Neurobiology of Aging|November 11, 2022
CSF peptides from VGF and other markers enhance prediction of MCI to AD progression using the ATN frameworkDaniel A Llano, Priya Devanarayan, Viswanath Devanarayan, et al.
Alzheimer Disease and Associated Disorders|September 18, 2010
Derivation of a new ADAS-cog composite using tree-based multivariate analysis: prediction of conversion from mild cognitive impairment to Alzheimer diseaseDaniel A Llano, Genevieve Laforet, Viswanath Devanarayan, et al.
Alzheimer Disease and Associated Disorders|July 16, 2019
VGF in Cerebrospinal Fluid Combined With Conventional Biomarkers Enhances Prediction of Conversion From MCI to ADDaniel A Llano, Priya Devanarayan, Viswanath Devanarayan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 20, 2018
Intelligent and effective informatic deconvolution of "Big Data" and its future impact on the quantitative nature of neurodegenerative disease therapyStuart Maudsley, Viswanath Devanarayan, Bronwen Martin, et al.
Statistics in Medicine|October 28, 2014
A PRIM approach to predictive-signature development for patient stratificationGong Chen, Hua Zhong, Anton Belousov, et al.
Frontiers in Human Neuroscience|October 11, 2021
Reported Hearing Loss in Alzheimer's Disease Is Associated With Loss of Brainstem and Cerebellar VolumeDaniel A Llano, Susanna S Kwok, Viswanath Devanarayan, et al.
Pageof 7